The Decentralized Clinical Trials Outlook is an interactive visualizer designed to support learning about where decentralized oncology trials could be practically considered in the United States. It brings together clinical, workforce, and infrastructure indicators to help users interpret geographic differences in trial readiness.
The visualizer exists to encourage informed reflection rather than prescription. By presenting key variables side by side, it helps clinical, operational, and regulatory stakeholders consider how patient access, medical expertise, and digital connectivity intersect when planning decentralized approaches.
How the visualizer supports structured exploration
Examine Patient Concentration
Assess Medical Expertise Availability
Consider Digital Feasibility
The visualizer combines publicly available data from U.S. cancer profiles, healthcare services, and broadband coverage sources, with the most recent updates ranging from 2021 to 2023. The visual logic is intentionally transparent, allowing users to interpret how each variable contributes to the overall picture without implying causality or suitability for a specific trial design.
What does “potential” mean in this context?
Use the visual patterns to ask informed questions about access and feasibility. The visualizer is a starting point for discussion, not a decision-making tool.
The eyesON series is a collection of interactive visual tools created to support learning and interpretation in clinical research, quality, and regulatory contexts. Each visualizer focuses on making complex datasets easier to explore without simplifying the underlying realities.
Cyntegrity offers the eyesON series as a way to contribute practical, openly accessible learning tools to the wider research community, drawing on internal experience in data analysis and clinical operations. Explore More Interactive Visualizers…
See how other datasets can sharpen signal awareness and decision-making.
Need a quote, speaker, or more info about Cyntegrity? Reach out directly to our media contact for timely assistance.
Featured Insights
Start Your Roll-Out
Quick Answers
